WTC
FOLD

WhitTier Trust Company’s Amicus Therapeutics FOLD Stock Holding History

WhitTier Trust Company’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-198
Closed -$1.86K – 1437
2024
Q4 		$1.86K Sell
198
-4
-2% -$42 ﹤0.01% 1244
2024
Q3 		$2.16K Sell
202
-127
-39% -$1.38K ﹤0.01% 1218
2024
Q2 		$3.26K Hold
329
– – ﹤0.01% 1125
2024
Q1 		$3.88K Sell
329
-22
-6% -$281 ﹤0.01% 1064
2023
Q4 		$4.98K Hold
351
– – ﹤0.01% 1037
2023
Q3 		$4.27K Hold
351
– – ﹤0.01% 1003
2023
Q2 		$4.41K Buy
351
+7
+2% +$83 ﹤0.01% 1035
2023
Q1 		$3.81K Buy
+344
New +$4.24K ﹤0.01% 1040

Other funds holding FOLD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

WhitTier Trust Company's FOLD Position: Q1 2025 in Review

WhitTier Trust Company sold out of Amicus Therapeutics (FOLD) in Q1 2025, closing a stake of 198 shares — an estimated $1.86K sold.

WhitTier Trust Company first reported a position in FOLD in Q1 2023 and held it in 8 quarters. The position peaked at $4.98K in Q4 2023. 286 funds tracked by Wall St. Rank hold FOLD as of Q1 2025.

  • WhitTier Trust Company reported no remaining Amicus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 198 Amicus Therapeutics shares in Q1 2025, an estimated $1.86K.
  • WhitTier Trust Company first reported a position in Amicus Therapeutics in Q1 2023 and held it in 8 quarters.
  • WhitTier Trust Company's Amicus Therapeutics position peaked at $4.98K in Q4 2023.
  • 286 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2025.

Based on WhitTier Trust Company's 13F filing for Q1 2025, filed 2 May 2025.